Clinical Trial Update: Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery [Phase 1, Phase 2]

View source ↗

Summary

Bevonescein was studied in a Phase 1/2 trial to highlight nerves during head and neck surgery, including procedures for parotid and thyroid neoplasms, with the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Neoplasms
• Parotid Neoplasms
• Thyroid Neoplasms

Drugs mentioned

• Bevonescein (Bevonescein)

Snippet

Sponsor: Alume Biosciences, Inc. | Conditions: Parotid Neoplasm, Thyroid Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-05-08